74 related articles for article (PubMed ID: 11227331)
1. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan.
Hirata S; Nakamura Y; Yanagawa H
Acta Paediatr; 2001 Jan; 90(1):40-4. PubMed ID: 11227331
[TBL] [Abstract][Full Text] [Related]
2. Seasonality and temporal clustering of Kawasaki syndrome.
Burns JC; Cayan DR; Tong G; Bainto EV; Turner CL; Shike H; Kawasaki T; Nakamura Y; Yashiro M; Yanagawa H
Epidemiology; 2005 Mar; 16(2):220-5. PubMed ID: 15703537
[TBL] [Abstract][Full Text] [Related]
3. Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature.
Medaglia AA; Siracusa L; Gioè C; Giordano S; Cascio A; Colomba C
Ital J Pediatr; 2021 Apr; 47(1):95. PubMed ID: 33874991
[TBL] [Abstract][Full Text] [Related]
4. Prevention Measures for COVID-19 and Changes in Kawasaki Disease Incidence.
Katsumata N; Harama D; Toda T; Sunaga Y; Yoshizawa M; Kono Y; Hasebe Y; Koizumi K; Hoshiai M; Saito T; Hokibara S; Kobayashi K; Goto M; Sano T; Tsuruta M; Nakamura M; Mizorogi S; Ohta M; Mochizuki M; Sato H; Yokomichi H; Inukai T
J Epidemiol; 2021 Nov; 31(11):573-580. PubMed ID: 34483151
[TBL] [Abstract][Full Text] [Related]
5. Epidemiologic features of Kawasaki disease in acute stages in Taiwan, 1997-2010: effect of different case definitions in claims data analysis.
Lin MC; Lai MS; Jan SL; Fu YC
J Chin Med Assoc; 2015 Feb; 78(2):121-6. PubMed ID: 25636582
[TBL] [Abstract][Full Text] [Related]
6. Kawasaki Disease Before and During the COVID-19 Pandemic: A Nationwide Population-based Study in the United States.
Sakai-Bizmark R; Estevez D; Wu F; Marr EH; BenDavid E; Mena LA; Chang RR
Pediatr Infect Dis J; 2024 Jan; 43(1):7-13. PubMed ID: 37725798
[TBL] [Abstract][Full Text] [Related]
7. A prediction model for differentiating recurrent Kawasaki disease from other febrile illnesses.
Yang P; Zhang J; Feng S; Yi Q
Eur J Intern Med; 2024 Jul; 125():148-151. PubMed ID: 38519309
[No Abstract] [Full Text] [Related]
8. Rate, associated factors and outcomes of recurrence of Kawasaki disease in Ontario, Canada.
Chahal N; Somji Z; Manlhiot C; Clarizia NA; Ashley J; Yeung RS; McCrindle BW
Pediatr Int; 2012 Jun; 54(3):383-7. PubMed ID: 22631567
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of recurrent Kawasaki disease and its risk factors.
Yang HM; Du ZD; Fu PP
Eur J Pediatr; 2013 Dec; 172(12):1641-7. PubMed ID: 23887608
[TBL] [Abstract][Full Text] [Related]
10. Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan.
Sudo D; Makino N; Nakamura Y
Arch Dis Child; 2020 Sep; 105(9):848-852. PubMed ID: 32107252
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Kawasaki disease: USA and Japan.
Maddox RA; Holman RC; Uehara R; Callinan LS; Guest JL; Schonberger LB; Nakamura Y; Yashiro M; Belay ED
Pediatr Int; 2015 Dec; 57(6):1116-20. PubMed ID: 26096590
[TBL] [Abstract][Full Text] [Related]
12. Cardiac sequelae in recurrent cases of Kawasaki disease: a comparison between the initial episode of the disease and a recurrence in the same patients.
Nakamura Y; Oki I; Tanihara S; Ojima T; Yanagawa H
Pediatrics; 1998 Dec; 102(6):E66. PubMed ID: 9832594
[TBL] [Abstract][Full Text] [Related]
13. Incidence rate of recurrent Kawasaki disease in Japan.
Nakamura Y; Hirose K; Yanagawa H; Kato H; Kawasaki T
Acta Paediatr; 1994 Oct; 83(10):1061-4. PubMed ID: 7841705
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features of children with recurrent Kawasaki disease: a Meta analysis].
Luo G; Pan SL; Wang SB; DU ZH; Ji ZX
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Dec; 22(12):1306-1312. PubMed ID: 33328002
[TBL] [Abstract][Full Text] [Related]
15. Kawasaki disease: epidemiology and the lessons from it.
Nakamura Y
Int J Rheum Dis; 2018 Jan; 21(1):16-19. PubMed ID: 29115029
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatic analysis of underlying mechanisms of Kawasaki disease via Weighted Gene Correlation Network Analysis (WGCNA) and the Least Absolute Shrinkage and Selection Operator method (LASSO) regression model.
Xie Y; Shi H; Han B
BMC Pediatr; 2023 Feb; 23(1):90. PubMed ID: 36829193
[TBL] [Abstract][Full Text] [Related]
17. Using bioinformatics analysis to screen abnormal methylated differentially expressed hub genes of Kawasaki disease and construct diagnostic model.
Sun H; Liu C; Zhang X; Liu P; Du Z; Luo G; Pan S
Heliyon; 2022 Nov; 8(11):e11905. PubMed ID: 36458298
[TBL] [Abstract][Full Text] [Related]
18. Changes in the Clinical Characteristics of Kawasaki Disease After Coronavirus Disease (COVID-19) Pandemic: A Database Analysis.
Kim BJ; Choi A; Kim HS; Oh JH; Lee JY; Kim S; Han JW; Kim K; Kim HH
J Korean Med Sci; 2022 May; 37(20):e141. PubMed ID: 35607738
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors and Predictive Models for Intravenous Immunoglobulin Resistance in Children with Recurrent Kawasaki Disease.
Chen X; Gao L; Zhen Z; Wang Y; Na J; Yu W; Chu X; Yuan Y; Qian S
J Inflamm Res; 2022; 15():2877-2889. PubMed ID: 35571506
[TBL] [Abstract][Full Text] [Related]
20. G0S2 regulates innate immunity in Kawasaki disease via lncRNA HSD11B1-AS1.
Okabe M; Takarada S; Miyao N; Nakaoka H; Ibuki K; Ozawa S; Watanabe K; Tsuji H; Hashimoto I; Hatasaki K; Hayakawa S; Hamaguchi Y; Hamada M; Ichida F; Hirono K
Pediatr Res; 2022 Aug; 92(2):378-387. PubMed ID: 35292727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
